  The acoustic contrast factor (ACF) is calculated from the relative density
and compressibility differences between a fluid and an object in the fluid. To
name but one application, this acoustic contrast can be exploited using
acoustophoretic systems to isolate cancer cells from a liquid biopsy, such as a
blood sample. Knowing the ACF of a cancer cell represents a crucial step in the
design of acoustophoretic systems for this purpose, potentially allowing the
isolation of circulating cancer cells without labels or contact. For biological
cells the static compressibility is different from the high frequency
counterpart relevant for the ACF. In this study, we started by characterizing
the ACF of low vs. high metastatic cell lines with known associated differences
in phenotypic static E-modulus. The change in the static E-modulus, however,
was not reflected in a change of the ACF, prompting a more in depth analysis of
the influences on the ACF. We demonstrate that static E-modulus increased
biological cells through formaldehyde fixation have an increased ACF.
Conversely static E-modulus decreased biological cells treated with actin
polymerization inhibitor cytochalasin D have a decreased ACF. Complementing
these mechanical tests, a numerical COMSOL model was implemented and used to
parametrically explore the effects of cell density, cell density ratios,
dynamic compressibility and therefore the dynamic bulk modulus. Collectively
the combined laboratory and numerical experiments reveal that a change in the
static E-modulus alone might, but does not automatically lead to a change of
the dynamic ACF for biological cells. This highlights the need for a
multiparametic view of the biophysical basis of the cellular ACF, as well as
the challenges in harnessing acoustophoretic systems to isolate circulating
cells based on their mechanical properties alone.
